Noema Pharma
Phase 1DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $166M
About
DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
Small Molecules
Funding History
2Total raised:$166M
Series B$112MJan 15, 2022
Series A$54MJun 15, 2020